A study of human cardiac tissue shows that CTGF mediates the profibrotic effects of MAS in cardiac fibroblasts. The findings suggest a promising target for heart failure drug intervention.Read More
One of the world’s premier hemispherectomy specialists looks back to epilepsy surgery’s Neolithic origins — and ahead to what blows him away about today’s neurosurgery residents.
As CEO of Cleveland Clinic London, Brian Donley, MD, will direct strategy and operations, guide recruitment and lead the opening of the new 200-bed private healthcare facility near Buckingham Palace.
Listening to patients’ stories, finding out what gives their life meaning and what brings them joy inspires this physician.
The task force’s draft recommendation against using the ABI to assess for peripheral artery disease in asymptomatic adults would perpetuate underdiagnosis, argues Dr. Heather Gornik.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Microvascular surgeons conducted a study to assess the accuracy of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Surgical Risk Calculator. Specifically, they looked at predicted outcomes for patients undergoing head and neck free flap reconstruction.
In this short video, Brian Bolwell, MD, Chair of Cleveland Clinic Cancer Center, argues that you must study leadership the same way you studied medicine if you want to become an effective, transformative leader.
By demonstrating the most dramatic reversal of amyloid deposition in an Alzheimer’s disease mouse model to date, a new study gives renewed support to the BACE1 inhibitor class in human trials.
For the first time, research suggests that Akt3 protects against diet-related obesity in a preclinical model by suppressing a mechanism of adipogenesis. Eugene Podrez, MD, PhD, explains.
In addition to determining the probability of finding N2 or N3 disease on EBUS-TBNA the model is also able to predict the presence of mediastinal disease when EBUS-TBNA nodal sampling is negative.